Dermatitis

Children born to mothers with atopic dermatitis are more prone to develop atopic dermatitis as well as other allergic illnesses, according to a study.

Long-term trial results showed efficacy of rademikibart in Chinese patients with moderate to severe atopic dermatitis, Connect Biopharma announced in a press release.

The European Commission has approved Ebglyss in the European Union for the treatment of moderate to severe atopic dermatitis in adults and adolescents aged 12 years and older, Almirall announced in a press release.

ANAHEIM, Calif. — Tapinarof cream was well tolerated and significantly improved itch in adults and children aged as young as 2 years with atopic dermatitis, according to a poster presentation here.

In patients with atopic dermatitis treated with dupilumab, a reversible and most likely benign lymphoid reaction could occur, according to a study.

CHICAGO — Isotretinoin can be a helpful addition to the toolbox for seborrheic dermatitis treatment, according to a study presented at the American Society for Dermatologic Surgery Annual Meeting.

Patients being treated for atopic dermatitis with dupilumab had good reproducibility with patch testing for allergic contact dermatitis, according to a study.

Maintenance dosing of lebrikizumab sustained skin clearance, relieved itch and reduced disease severity for up to 2 years in patients with moderate to severe atopic dermatitis, Eli Lilly and Company announced in a press release.

Galderma has announced positive data from three phase 3 studies that evaluated nemolizumab for the treatment of atopic dermatitis and prurigo nodularis, according to a company press release.

Rinvoq showed long-term efficacy and safety up to 140 weeks in the treatment of moderate to severe atopic dermatitis in adults and adolescents aged 12 years and older, AbbVie announced in a press release.